Unlock instant, AI-driven research and patent intelligence for your innovation.

Aldose reductase inhibitor, preparation method and use thereof

A glycosyl and diabetes technology, applied to aldose reductase inhibitors, can solve problems such as undiscovered glycoside activity

Inactive Publication Date: 2008-07-09
华北制药华胜有限公司
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0010] However, they did not find the activity of glycosides formed by Genestein as aglycone in the treatment of cataracts.
[0011] Although there are drugs for the prevention of diabetic complications, they still cannot meet the needs of the market. The market still needs alternative drugs for the prevention or treatment of diabetic complications, especially alternative drugs of natural origin.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Aldose reductase inhibitor, preparation method and use thereof
  • Aldose reductase inhibitor, preparation method and use thereof
  • Aldose reductase inhibitor, preparation method and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0134] training method

[0135] The slant of actinomycetes N99-596 was inoculated in the seed medium, and after 72hr cultivation at 27°C, it was inserted into a 750ml Erlenmeyer flask with a content of 140ml medium, and shaken and cultured in the fermentation medium at 27°C for 6 days.

[0136] Separation method

[0137] Centrifuge 5000ml of N99-596 fermentation broth at 3000rpm for 15 minutes, collect the bacteria and supernatant respectively, extract the bacteria with 2000ml of acetone, evaporate the acetone, extract twice with 2500mL ethyl acetate, and wash the ethyl acetate layer through anhydrous Na 2 SO 4 After dehydration, concentration and drying, 2.2 g of brown substance was obtained.

[0138] Take 2.2g sample, dissolve it with a small amount of methanol, use silica gel column (φ2.5×25cm) chromatography to carry out further separation and purification, and the elution condition of the chromatography column is 100% CHCl 3 After elution to 100% MeOH, the combined act...

Embodiment 2

[0167] Preparation of aldose reductase

[0168] The following operations were all carried out at 0-4°C. Take about 90g of porcine lens from each batch, homogenize in three times the volume of cold NaPi buffer, and centrifuge at 10,000×g for 50 minutes to remove insoluble matter. Add (NH 4 ) 2 SO 4 to 40% saturation, stirred gently for 15 minutes, centrifuged to remove the precipitate, and then added (NH 4 ) 2 SO 4 to 50% saturation, stirred gently for 15 minutes, centrifuged to remove precipitate, added (NH 4 ) 2 SO 4 To 75% saturation, gently stirred for 15 minutes to collect the precipitate by centrifugation, dissolved with cold 0.05mol / L NaPi (containing 0.5mmol / lPMSF and 0.5mmol / lEtSH), and dissolved in 0.05mol / L NaPi solution (containing 0.5 mmol / l PMSF and 0.5mmol / l EtSH) and dialyzed overnight. After dialysis, the above enzyme solution was added to glycerol to a concentration of 40%, and stored at -20°C for future use.

[0169] Compound activity assay method:

...

Embodiment 3

[0177] The cultivation method of N99-253 is identical with the cultivation method of N99-596 among the embodiment 1.

[0178] Separation method:

[0179] 5000ml of N99-253 (46) fermentation broth was centrifuged at 3000rpm for 15 minutes, and the bacteria and supernatant were collected respectively. After the bacteria were extracted with 2000ml of acetone, the acetone was evaporated, extracted twice with 2500mL ethyl acetate, and the ethyl acetate layer was Anhydrous Na 2 SO 4After dehydration, concentration and drying, 1.2g of brown substance was obtained.

[0180] Take 1.0g sample, dissolve it with a small amount of methanol, and use silica gel column (φ2.5×25cm) chromatography for further separation and purification. The elution condition of the chromatography column is CHCl 3 : MeOH 100: 0~0~100 gradient elution, the combined active components were collected, concentrated and dried to obtain 118mg of brown solid.

[0181] Get above-mentioned active substance, use ODS r...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
wavelengthaaaaaaaaaa
Login to View More

Abstract

The invention provides compounds having a general formula (I), their preparation method and pharmaceutical compositions containing them, wherein said compounds and pharmaceutical compositions containing them can be used for treating diabetes and syndromes. The invention also provides two novel microorganisms.

Description

technical field [0001] The present invention relates to a kind of new aldose reductase inhibitor, its preparation method and its use, more specifically, the present invention relates to the compound of general formula (I) as aldose reductase inhibitor, the pharmaceutical composition containing them , a method for preparing a compound of general formula (I) by microbial fermentation and a new microorganism used therein, and the use of a compound of general formula (I) or a pharmaceutical composition containing them in the preparation of a medicament for preventing diabetic complications. Background technique [0002] Diabetes is a syndrome caused by the absolute or relative weakening of insulin secretion and / or insulin action, mainly manifested as hyperglycemia. Diabetes is divided into insulin-dependent diabetes (type I diabetes) and insulin-independent diabetes (type II diabetes) , Complications may occur in the late stage of type II diabetes, among which microvascular comp...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D311/36C07D407/04C07H17/07C12P17/06C12P19/44A61K31/352A61K31/7048A61P3/10
Inventor 吕渭川张华董悦生任晓任凤芝郑智慧路新华倪慧敏李韶菁林洁杨健舒薇马英单越琦贺秉坤
Owner 华北制药华胜有限公司